Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Cash from Investing Activities (2016 - 2025)

Tg Therapeutics (TGTX) has 10 years of Cash from Investing Activities data on record, last reported at -$15.6 million in Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 199.05% year-over-year to -$15.6 million; the TTM value through Dec 2025 reached $13.8 million, up 1431.95%, while the annual FY2025 figure was $13.8 million, 1431.95% up from the prior year.
  • Cash from Investing Activities reached -$15.6 million in Q4 2025 per TGTX's latest filing, down from $46.4 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $46.4 million in Q3 2025 and bottomed at -$44.8 million in Q4 2023.
  • Average Cash from Investing Activities over 5 years is -$2.9 million, with a median of -$2.7 million recorded in 2021.
  • Peak YoY movement for Cash from Investing Activities: plummeted 8396.3% in 2022, then surged 596.71% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at $3.3 million in 2021, then skyrocketed by 394.8% to $16.3 million in 2022, then plummeted by 375.09% to -$44.8 million in 2023, then skyrocketed by 135.28% to $15.8 million in 2024, then tumbled by 199.05% to -$15.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were -$15.6 million in Q4 2025, $46.4 million in Q3 2025, and -$4.0 million in Q2 2025.